Improving care for young adults with GI cancer
Part of Cancer, Digestive system clinical trials.
This study aims to improve care for younger adults (ages 18-50) with gastrointestinal (GI) tumors. Researchers will test ways to better support patients during and after treatment. If you are 18-50 and being treated for a GI tumor at Heidelberg University Hospital, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old
- You are being treated for a gastrointestinal (GI) tumor at Heidelberg University Hospital
- You understand and speak German well enough for conversations about the study
- You are able to understand what the study involves and give your permission
- You do not have severe memory or thinking problems that would make it hard to take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to improve health and care support for people age 70 and older with gastrointestinal (GI) cancer. It may help by offering a structured way to address practical and emotional challenges that can affect aging and cancer care.
This study is looking at whether people with certain gastrointestinal cancers who have had a very good response to targeted therapy or immunotherapy might be able to avoid surgery for now and instead be closely monitored. The goal is to see if this non-surgical approach is safe and effective.
This study looks at gastrointestinal cancers (like colorectal, stomach, esophagus, and pancreatic) in people diagnosed between ages 18 and 49. It aims to understand how tumor features and lifestyle habits are related, and it does not test a new treatment.
This trial tests a program to help improve mental health and quality of life for teenagers and young adults who have had a solid tumor cancer, and for their caregivers. It focuses on those recently finished treatment or still in treatment, and aims to provide supportive counseling.
This study tests a special geriatric (older-adult) care program for people over 65 with advanced stomach, bile duct, or pancreatic cancer who are receiving palliative chemotherapy. The goal is to see if extra support from a geriatric team can help improve quality of life and treatment outcomes.
This study looks at rare types of gastrointestinal (GI) cancer and may match you to a targeted treatment. It also collects blood and other samples to better understand your cancer and help researchers learn what works.
Hear when a new Gastrointestinal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.